A Comparative Study of KSO-0400 in BPH Patients With LUTS

• Status: Completed
• Trial end date: 1969-12-31
• Target enrollment: 0
• Participant gender: Male

Summary

The objective of this study is to evaluate the efficacy and safety of KSO-0400 compared to placebo for the treatment of LUTS caused by BPH.

• Phase: Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Kissei Pharmaceutical Co., Ltd.
• Treatments: Silodosin

Criteria

Inclusion Criteria:

• BPH patients with LUTS

Exclusion Criteria:

• Patients with a history of prostatectomy, intrapelvic radiation therapy, thermotherapy of prostate or prostatic hyperthermia

• Patients with prostate cancer or suspected prostate cancer

• Patients who have any clinically relevant cardiovascular, hepatic or renal disorder